Research graph
References from Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Epidemiology and molecular biology of head and neck cancer
10.1159/000477127 · 2017 · External reference
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
10.1016/j.oraloncology.2018.04.008 · 2018 · External reference
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
10.1016/s0140-6736(18)31999-8 · 2019 · External reference
The immune system in cancer prevention, development and therapy
10.2174/1871520615666150824153523 · 2016 · External reference
10.1038/nrclinonc.2017.101
10.1038/nrclinonc.2017.101 · External reference
Nivolumab in squamous cell carcinoma of the head and neck
10.1080/14737140.2018.1456337 · 2018 · External reference
FDA approval summary: pembrolizumab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma with disease progression on or after platinum-containing chemotherapy
10.1634/theoncologist.2016-0496 · 2017 · External reference
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
10.1186/s40425-019-0662-5 · 2019 · External reference
10.1038/ng.2764
10.1038/ng.2764 · External reference
Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth
10.1096/fj.201802213rr · 2019 · External reference
10.1007/s12026-014-8516-1
10.1007/s12026-014-8516-1 · External reference
10.1093/nar/gkv007
10.1093/nar/gkv007 · External reference
10.1111/j.1467-985x.2010.00676_9.x
10.1111/j.1467-985x.2010.00676_9.x · External reference
10.1038/nprot.2008.211
10.1038/nprot.2008.211 · External reference
The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: a study based on TCGA and Cmap datasets
2019 · External reference
The Gene Ontology (GO) database and informatics resource
10.1093/nar/gkh036 · 2004 · External reference
10.18637/jss.v033.i01
10.18637/jss.v033.i01 · External reference
Unresolved reference
External reference
10.1111/j.0006-341x.2000.00337.x
10.1111/j.0006-341x.2000.00337.x · External reference
Unresolved reference
External reference
10.1038/nmeth.3337
10.1038/nmeth.3337 · External reference
10.1101/gr.239244.118
10.1101/gr.239244.118 · External reference
10.1016/j.celrep.2016.12.019
10.1016/j.celrep.2016.12.019 · External reference
10.1126/science.1132939
10.1126/science.1132939 · External reference
10.1038/nrc2044
10.1038/nrc2044 · External reference
10.1093/nar/gky1033
10.1093/nar/gky1033 · External reference
10.1093/nar/gky1131
10.1093/nar/gky1131 · External reference
The protein data bank
10.1107/s0907444902003451 · 2002 · External reference
Unresolved reference
External reference
10.1021/jm051256o
10.1021/jm051256o · External reference
10.1016/j.cell.2017.09.028
10.1016/j.cell.2017.09.028 · External reference
10.1038/s41591-018-0157-9
10.1038/s41591-018-0157-9 · External reference
10.1038/s41591-019-0349-y
10.1038/s41591-019-0349-y · External reference
10.1245/s10434-018-6658-4
10.1245/s10434-018-6658-4 · External reference
Immunotherapy of head and neck squamouscell carcinoma (HNSCC). Immune checkpoint blockade
10.5604/01.3001.0012.4367 · 2018 · External reference
10.1002/cncr.30449
10.1002/cncr.30449 · External reference
10.1056/nejmoa1805131
10.1056/nejmoa1805131 · External reference
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
10.1093/annonc/mdx178 · 2017 · External reference
10.2217/fon-2018-0405
10.2217/fon-2018-0405 · External reference
10.1056/nejmoa1602252
10.1056/nejmoa1602252 · External reference
10.1016/s1470-2045(16)30066-3
10.1016/s1470-2045(16)30066-3 · External reference
10.3389/fimmu.2018.02076
10.3389/fimmu.2018.02076 · External reference
10.1016/j.immuni.2018.03.004
10.1016/j.immuni.2018.03.004 · External reference
10.1016/j.coi.2016.02.001
10.1016/j.coi.2016.02.001 · External reference
Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer
10.1002/ijc.31573 · 2018 · External reference
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
10.1186/s12885-018-5206-8 · 2019 · External reference
Function of CSF1 and IL34 in macrophage homeostasis, inflammation, and cancer
2019 · External reference
10.1002/cmdc.201700429
10.1002/cmdc.201700429 · External reference
Klf4 regulates the expression of slurp1, which functions as an immunomodulatory peptide in the mouse cornea
10.1167/iovs.12-10759 · 2012 · External reference
Upregulation of stanniocalcin-1 inhibits the development of osteoarthritis by inhibiting survival and inflammation of fibroblast-like synovial cells
10.1002/jcb.28257 · 2019 · External reference
10.21037/atm.2020.02.105
10.21037/atm.2020.02.105 · External reference
IRF9 Prevents CD8+ T cell exhaustion in an extrinsic manner during acute lymphocytic choriomeningitis virus infection
10.1128/jvi.01219-17 · 2017 · External reference
10.1074/jbc.m010800200
10.1074/jbc.m010800200 · External reference
10.1038/msb.2012.56
10.1038/msb.2012.56 · External reference
10.3389/fimmu.2019.00583
10.3389/fimmu.2019.00583 · External reference
Hypoxia directed migration of human naïve monocytes is associated with an attenuation of cytokine release: indications for a key role of CCL26
10.1186/s12967-020-02567-7 · 2020 · External reference
Triggering of TNFRSF25 promotes CD8 + T-cell responses and anti-tumor immunity
10.1002/eji.201141477 · 2011 · External reference
Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis
10.1007/s10147-019-01435-9 · 2019 · External reference
10.1074/mcp.m112.020933
10.1074/mcp.m112.020933 · External reference
STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling
10.18632/oncotarget.13355 · 2017 · External reference
FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients
2017 · External reference
Drug targeting and biomarkers in head and neck cancers: insights from systems biology analyses
10.1089/omi.2018.0048 · 2018 · External reference
Effects of SEMA3G on migration and invasion of glioma cells
2012 · External reference
10.1371/journal.pone.0219195
10.1371/journal.pone.0219195 · External reference
Cd8+ and regulatory T cells differentiate tumor immune phenotypes and predict survival in locally advanced head and neck cancer
10.3390/cancers11091398 · 2019 · External reference
10.1038/s41598-019-52515-9
10.1038/s41598-019-52515-9 · External reference
Apoptotic capacity and risk of squamous cell carcinoma of the head and neck
10.1016/j.ejca.2016.11.018 · 2017 · External reference
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
10.1038/s41419-018-0700-0 · 2018 · External reference
Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma
10.1016/j.bbrc.2019.03.118 · 2019 · External reference
Antiviral therapy in patients with chronic hepatitis C is associated with a reduced risk of parkinsonism
10.1002/mds.27848 · 2019 · External reference
Identification of key candidate genes and pathways in oral squamous cell carcinoma by integrated Bioinformatics analysis
2019 · External reference
Weighted gene co-expression network analysis identifies hub genes associated with occurrence and prognosis of oral squamous cell carcinoma
10.12659/msm.916025 · 2019 · External reference
10.1111/jphp.12539
10.1111/jphp.12539 · External reference
10.4103/0973-1482.139267
10.4103/0973-1482.139267 · External reference
Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with pfv for the treatment of non-smallcell lung cancer
10.2147/ijn.s194304 · 2019 · External reference
